Everyone understands the pressures of working in a highly regulated market. Considering COVID pressures and a probable global recession, there needs to be an increased focus on cost-cutting. For banks looking to assist their clients through this phase of turbulence, could Earnings Credit Rates (ECR) help? Oracle’s Kiran Rajendran shares more.
The onset of the market-wide stress event that is national governments’ policy response to the coronavirus epidemic has thrown stress testing procedures, and capabilities, sharply into focus. Unlike in 2008, this time, banks are not part of the problem. Find out how banks are implementing stress testing.
Drug trafficking is a global problem—and despite decades of research, regulations, and enforcement, it remains a $400 billion global business. While financial institutions have invested heavily in innovative technology, they continue to miss a significant portion of drug trafficking activities. Oracle’s Garima Chaudhary shares her views on how advanced analytics can help.
After the global financial crisis, banks had to think about large scale restructuring to shore up balance sheets. Current business environment adds further complexities as bankers aim at boosting revenue while reducing costs. Oracle’s Darren Cherry shares his views on possible strategies to boost revenue with the right adoption of technology. Find out more.
Healthcare is a very personal and expensive proposition, and our “user experience” is often not on par with other services we consume in our daily lives. With rising user expectations, how can healthcare insurers keep pace with these changing requirements? Oracle’s Glenn shares his views.
COVID-19 and the economic slowdown as a result of it that places banks’ balance sheet under stress, but with a proactive approach to risk and finance, banks can build resilience and strength as they navigate through this. Oracle’s Nishit shares his views.